December 12th 2022, 4:00pm
CURE®’s Multiple Myeloma Heroes® Award Program honors and gives thanks to those who have made it their mission to change the lives of patients with multiple myeloma.
FDA Approves Breyanzi for Relapsed, Refractory Follicular Lymphoma
IMRT ‘Takes Precision to the Next Level’ in Prostate Cancer Radiation
Cancer and Fatigue Go Together
Chemo May Not Improve Recurrent Endometrial Cancer Outcomes